Search Results
NEJM Trial Summary: Duration of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer
An Overview of the MA17R Trial in Breast Cancer
02_03 Adjuvant endocrine therapy for early breast cancer
Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines
Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in HR+ Breast Cancer
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
Breast Cancer update - Webinar
The Latest in Breast Cancer Treatment and Prevention with Anne M. Wallace - Research on Aging
Special lecture III: Adjuvant & neoadjuvant therapy in patients with early breast cancer: Princi...
5. Early Hormone Receptor-Positive Breast Cancer
Safety and Efficacy Profile of Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer
Emerging Strategies in Breast Cancer Care Before, During and After Surgery
